Balance Sheet
Cash Flow Statement
AcquisitionsBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENvue Medical (FEED) Cash from Operations (2017 - 2025)

Historic Cash from Operations for ENvue Medical (FEED) over the last 11 years, with Q3 2025 value amounting to -$2.0 million.

  • ENvue Medical's Cash from Operations fell 13564.59% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.2 million, marking a year-over-year decrease of 19459.13%. This contributed to the annual value of -$2.5 million for FY2024, which is 3014.99% up from last year.
  • ENvue Medical's Cash from Operations amounted to -$2.0 million in Q3 2025, which was down 13564.59% from -$3.4 million recorded in Q2 2025.
  • Over the past 5 years, ENvue Medical's Cash from Operations peaked at -$491000.0 during Q4 2023, and registered a low of -$3.4 million during Q2 2025.
  • Over the past 5 years, ENvue Medical's median Cash from Operations value was -$1.2 million (recorded in 2023), while the average stood at -$1.3 million.
  • In the last 5 years, ENvue Medical's Cash from Operations skyrocketed by 6527.49% in 2023 and then tumbled by 51175.41% in 2025.
  • ENvue Medical's Cash from Operations (Quarter) stood at -$863000.0 in 2021, then plummeted by 54.23% to -$1.3 million in 2022, then surged by 63.11% to -$491000.0 in 2023, then fell by 11.61% to -$548000.0 in 2024, then plummeted by 259.49% to -$2.0 million in 2025.
  • Its last three reported values are -$2.0 million in Q3 2025, -$3.4 million for Q2 2025, and -$1.3 million during Q1 2025.